Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The United Laboratories International Holdings ( (HK:3933) ) has issued an update.
The United Laboratories International Holdings Limited has declared a final ordinary cash dividend of RMB 0.26 per share for the financial year ended 31 December 2025, subject to shareholder approval. The ex-dividend date is set for 7 July 2026, with the record date on 10 July 2026 and certain payment details, including default currency, exchange rate, and exact payment date, still to be announced.
The dividend timetable includes a latest time to lodge transfer documents on 8 July 2026 and a book closure period from 9 to 10 July 2026, handled via its Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. The announcement signals the company’s intention to return cash to shareholders for the 2025 financial year, though specific implications for yield and payout ratio remain undisclosed in the notice.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$12.50 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a Hong Kong–listed pharmaceutical company, identified as an equity issuer on the Stock Exchange of Hong Kong. It operates in the healthcare sector, focusing on the manufacture and sale of pharmaceutical products, with its shares traded under stock code 03933 in the Hong Kong market.
Average Trading Volume: 11,242,188
Technical Sentiment Signal: Hold
Current Market Cap: HK$20.26B
See more data about 3933 stock on TipRanks’ Stock Analysis page.